Julian Harrison
Stock Analyst at BTIG
(4.95)
# 149
Out of 5,090 analysts
513
Total ratings
45.6%
Success rate
37.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Julian Harrison
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CGEM Cullinan Therapeutics | Reiterated: Buy | $40 → $41 | $15.03 | +172.79% | 30 | Oct 27, 2026 | |
| JBIO Jade Biosciences | Reiterated: Buy | $77 | $14.06 | +447.65% | 20 | Oct 26, 2026 | |
| ORKA Oruka Therapeutics | Reiterated: Buy | $151 | $96.87 | +55.88% | 16 | Oct 26, 2026 | |
| AVTX Avalo Therapeutics | Reiterated: Buy | $58 → $10 | $7.17 | +39.47% | 12 | Oct 23, 2026 | |
| SYRE Spyre Therapeutics | Reiterated: Buy | $121 | $96.56 | +25.31% | 26 | Oct 19, 2026 | |
| LQDA Liquidia | Upgraded: Buy | $70 | $45.06 | +55.35% | 49 | Oct 14, 2026 | |
| RZLT Rezolute | Reiterated: Buy | $6 | $3.95 | +51.90% | 18 | Oct 14, 2026 | |
| NKTR Nektar Therapeutics | Reiterated: Buy | $178 | $38.87 | +357.94% | 23 | Oct 9, 2026 | |
| ABVX ABIVAX Société Anonyme | Reiterated: Buy | $175 | $86.59 | +102.10% | 18 | Oct 1, 2026 | |
| CLYM Climb Bio | Reiterated: Buy | $32 | $10.25 | +212.20% | 12 | Oct 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $728 | $598.72 | +21.59% | 20 | Oct 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $44 | $6.49 | +577.97% | 12 | Sep 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $46 | $31.48 | +46.12% | 8 | Sep 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $0.7065 | +466.17% | 15 | Sep 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $0.8022 | +1,146.57% | 8 | Aug 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $0.7928 | +530.68% | 9 | Aug 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $0.4681 | +754.52% | 22 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $11.78 | +154.67% | 33 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $21.22 | +97.93% | 5 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $58 | $19.90 | +191.46% | 8 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1 | $0.2895 | +245.42% | 14 | Mar 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $3.03 | +461.06% | 8 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $61 | $24.67 | +147.26% | 20 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $82 | $144.85 | -43.39% | 32 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $0.59 | n/a | 11 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $11.04 | n/a | 18 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $48.28 | n/a | 4 | Dec 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $8 | $3.97 | n/a | 16 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $6.14 | n/a | 13 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $150 → $50 | $1.51 | n/a | 5 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $4 | $0.000001 | n/a | 1 | May 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $27.28 | n/a | 3 | Apr 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 | $0.5603 | n/a | 2 | Apr 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $51 | $0.8589 | n/a | 1 | Apr 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $60 | $3.24 | n/a | 1 | Dec 9, 2020 |
Cullinan Therapeutics
Oct 27, 2026
Reiterated: Buy
Price Target: $40 → $41
Current: $15.03
Upside: +172.79%
Jade Biosciences
Oct 26, 2026
Reiterated: Buy
Price Target: $77
Current: $14.06
Upside: +447.65%
Oruka Therapeutics
Oct 26, 2026
Reiterated: Buy
Price Target: $151
Current: $96.87
Upside: +55.88%
Avalo Therapeutics
Oct 23, 2026
Reiterated: Buy
Price Target: $58 → $10
Current: $7.17
Upside: +39.47%
Spyre Therapeutics
Oct 19, 2026
Reiterated: Buy
Price Target: $121
Current: $96.56
Upside: +25.31%
Liquidia
Oct 14, 2026
Upgraded: Buy
Price Target: $70
Current: $45.06
Upside: +55.35%
Rezolute
Oct 14, 2026
Reiterated: Buy
Price Target: $6
Current: $3.95
Upside: +51.90%
Nektar Therapeutics
Oct 9, 2026
Reiterated: Buy
Price Target: $178
Current: $38.87
Upside: +357.94%
ABIVAX Société Anonyme
Oct 1, 2026
Reiterated: Buy
Price Target: $175
Current: $86.59
Upside: +102.10%
Climb Bio
Oct 1, 2026
Reiterated: Buy
Price Target: $32
Current: $10.25
Upside: +212.20%
Oct 1, 2026
Upgraded: Buy
Price Target: $728
Current: $598.72
Upside: +21.59%
Sep 29, 2026
Reiterated: Buy
Price Target: $44
Current: $6.49
Upside: +577.97%
Sep 22, 2026
Reiterated: Buy
Price Target: $46
Current: $31.48
Upside: +46.12%
Sep 14, 2026
Reiterated: Buy
Price Target: $4
Current: $0.7065
Upside: +466.17%
Aug 27, 2026
Reiterated: Buy
Price Target: $10
Current: $0.8022
Upside: +1,146.57%
Aug 19, 2026
Reiterated: Buy
Price Target: $5
Current: $0.7928
Upside: +530.68%
Aug 14, 2026
Reiterated: Buy
Price Target: $4
Current: $0.4681
Upside: +754.52%
Aug 10, 2026
Reiterated: Buy
Price Target: $30
Current: $11.78
Upside: +154.67%
Aug 5, 2026
Reiterated: Buy
Price Target: $42
Current: $21.22
Upside: +97.93%
Aug 3, 2026
Initiated Coverage: Buy
Price Target: $58
Current: $19.90
Upside: +191.46%
Mar 19, 2026
Reiterated: Buy
Price Target: $1
Current: $0.2895
Upside: +245.42%
Feb 20, 2026
Reiterated: Buy
Price Target: $17
Current: $3.03
Upside: +461.06%
Nov 4, 2025
Reiterated: Buy
Price Target: $61
Current: $24.67
Upside: +147.26%
Nov 3, 2025
Reiterated: Buy
Price Target: $82
Current: $144.85
Upside: -43.39%
Mar 31, 2025
Reiterated: Buy
Price Target: $14
Current: $0.59
Upside: n/a
Dec 12, 2024
Downgraded: Hold
Price Target: n/a
Current: $11.04
Upside: n/a
Dec 2, 2024
Downgraded: Hold
Price Target: n/a
Current: $48.28
Upside: n/a
Nov 18, 2024
Upgraded: Buy
Price Target: $8
Current: $3.97
Upside: n/a
Nov 13, 2024
Reiterated: Buy
Price Target: $24
Current: $6.14
Upside: n/a
Nov 9, 2023
Rated: Buy
Price Target: $150 → $50
Current: $1.51
Upside: n/a
May 3, 2022
Initiated Coverage: Buy
Price Target: $4
Current: $0.000001
Upside: n/a
Apr 28, 2021
Reiterated: Buy
Price Target: $12
Current: $27.28
Upside: n/a
Apr 27, 2021
Reiterated: Buy
Price Target: $29
Current: $0.5603
Upside: n/a
Apr 20, 2021
Initiated Coverage: Buy
Price Target: $51
Current: $0.8589
Upside: n/a
Dec 9, 2020
Initiated Coverage: Buy
Price Target: $60
Current: $3.24
Upside: n/a